Rituximab as an immunosuppressant in antineutrophil cytoplasmic antibody-associated vasculitis

BACKGROUND: Rituximab has been used in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) since 2003. Our objective was to describe outcomes and adverse events following rituximab since that time in an inception cohort. METHODS: Patients with AAV (diagnosed 1991–2012) who receive...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Nephrol Dial Transplant
Egile Nagusiak: McGregor, JulieAnne G., Hogan, Susan L., Kotzen, Elizabeth S., Poulton, Caroline J., Hu, Yichun, Negrete-Lopez, Roberto, Kidd, Jason M., Katsanos, Suzanne L., Bunch, Donna O., Nachman, Patrick H., Falk, Ronald J.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Oxford University Press 2015
Gaiak:
Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4447867/
https://ncbi.nlm.nih.gov/pubmed/25805743
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ndt/gfv076
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak